Mycotopia Therapies Inc
Mycotopia Therapies, Inc. focuses on psychedelics for the treatment of mental health issues. It provides psychedelic therapies for the treatment of post-traumatic stress disorder, palliative care, depression, and anxiety. The company is based in Miami, Florida. Mycotopia Therapies, Inc. is a subsidiary of EHAVE, Inc.
Market Cap & Net Worth: Mycotopia Therapies Inc (TPIA)
Mycotopia Therapies Inc (PINK:TPIA) has a market capitalization of $179.73K ($179.73K) as of March 19, 2026. Listed on the PINK stock exchange, this USA-based company holds position #40706 globally and #13202 in its home market, demonstrating a -41.41% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Mycotopia Therapies Inc's stock price $0.03 by its total outstanding shares 5990900 (5.99 Million).
Mycotopia Therapies Inc Market Cap History: 2015 to 2025
Mycotopia Therapies Inc's market capitalization history from 2015 to 2025. Data shows change from $3.06 Million to $179.73K (-26.34% CAGR).
Mycotopia Therapies Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Mycotopia Therapies Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.01x
Mycotopia Therapies Inc's market cap is 0.01 times its annual revenue
1728.56x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
1.39x
Mycotopia Therapies Inc's market cap is 1.39 times its annual earnings
0.11x
Higher than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $3.06 Million | $12.82 Million | $72.35K | 0.24x | 42.23x |
| 2017 | $180.33K | $14.87 Million | $129.82K | 0.01x | 1.39x |
Competitor Companies of TPIA by Market Capitalization
Companies near Mycotopia Therapies Inc in the global market cap rankings as of March 19, 2026.
Key companies related to Mycotopia Therapies Inc by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #162 globally with a market cap of $117.09 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #281 globally with a market cap of $74.80 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #344 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #500 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #162 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $117.09 Billion | $462.49 |
| #281 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $74.80 Billion | $759.05 |
| #344 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #500 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
Mycotopia Therapies Inc Historical Marketcap From 2015 to 2025
Between 2015 and today, Mycotopia Therapies Inc's market cap moved from $3.06 Million to $ 179.73K, with a yearly change of -26.34%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $179.73K | +100.00% |
| 2024 | $89.86K | -6.25% |
| 2023 | $95.85K | -91.11% |
| 2022 | $1.08 Million | -91.98% |
| 2021 | $13.44 Million | +180.38% |
| 2020 | $4.79 Million | +376.19% |
| 2019 | $1.01 Million | -32.80% |
| 2018 | $1.50 Million | +730.56% |
| 2017 | $180.33K | -94.10% |
| 2016 | $3.06 Million | 0.00% |
| 2015 | $3.06 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Mycotopia Therapies Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $179.73K USD |
| MoneyControl | $179.73K USD |
| MarketWatch | $179.73K USD |
| marketcap.company | $179.73K USD |
| Reuters | $179.73K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.